Disclosed herein are compounds and compositions useful in the treatment of MCT4 mediated diseases, such as proliferative and inflammatory diseases, having the structure of Formula I:
Methods of inhibition MCT4 activity in a human or animal subject are also provided.
Vinyldiazo compounds undergo a thermal electrocyclization to form pyrazoles in yields of up to 95%. The reactions are operationally simple, use readily available starting materials, require no intervention of a catalyst, and enable the synthesis of mono-, di- and tri-substituted pyrazoles. With the ability to produce highly substituted pyrazoles and the flexibility in installing various types of substituents
[EN] COMPOUNDS AND THEIR USE AS PDE4 ACTIVATORS<br/>[FR] COMPOSÉS ET LEUR UTILISATION EN TANT QU'ACTIVATEURS DE PDE4
申请人:MIRONID LTD
公开号:WO2018060704A1
公开(公告)日:2018-04-05
Compounds of Formula (I), which are activators of long form cyclic nucleotide phosphodiesterase-4 (PDE4) enzymes (isoforms) are provided. Methods and uses of these compounds for the treatment or prevention of disorders requiring a reduction of second messenger responses mediated by cyclic 3', 5'-adenosine monophosphate (cAMP) are also described. (Formula (I))
Formula (I)的化合物是长形环核苷酸磷酸二酯酶-4(PDE4)酶(同工酶)的激活剂。还描述了这些化合物用于治疗或预防需要通过环3',5'-腺苷酸单磷酸(cAMP)介导的第二信使反应减少的疾病的方法和用途。